Allopurinol Tablet
Product Images NDC 16729-135

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 16729-135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Allopurinol Fig 1)

This is a chemical structure diagram showing the conversion of hypoxanthine to xanthine to uric acid through various compounds, including allopurinol and osipurinol. The text also includes the chemical names for these compounds in addition to 1,5-dihydro-4H-pyrazolo- 1Hpyrazolo [34-d][3.4-d]pyrimidin-3-one and various derivatives of purine.*

FDA Label Image

Structural Formula (Allopurinol Structure)

FDA Label Image

100 mg 500 Tablets Bottle (Allopurinol Tablets 100 500)

FDA Label Image

300 mg 500 Tablets Bottle (Allopurinol Tablets 300 500)

Each tablet of Allopurinol USP 300 mg is meant to be stored at a controlled room temperature of 20° to 25°C (68° to 77°F) and dispensed in a tight-resistant container as defined in USP. The manufacturer is Accord Healthcare, Inc., located in Durham, NC 27703, and the tablets are manufactured by Intas Pharmaceuticals Limited, located at Pharmez, Ahmedabad -382 213. The tablets come in a bottle of 500, and for further information regarding usage, dosage, and necessary precautions, see the package insert. The text also contains additional details such as NDC code 16720-139-16 and Mig. Lic. No.: G/25/1883.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.